Jazz Pharmaceuticals plc
JAZZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,999,733 | $6,493,907 | $7,570,543 | $7,455,255 |
| - Cash | $1,326,070 | $1,189,880 | $1,861,946 | $2,412,864 |
| + Debt | $1,082,605 | $5,433,084 | $5,419,705 | $6,162,357 |
| Enterprise Value | $7,756,268 | $10,737,111 | $11,128,302 | $11,204,748 |
| Revenue | $1,126,107 | $1,045,712 | $897,841 | $1,088,173 |
| % Growth | 7.7% | 16.5% | -17.5% | – |
| Gross Profit | $868,347 | $929,444 | $793,221 | $959,460 |
| % Margin | 77.1% | 88.9% | 88.3% | 88.2% |
| EBITDA | $235,857 | -$514,182 | $138,861 | $396,981 |
| % Margin | 20.9% | -49.2% | 15.5% | 36.5% |
| Net Income | $251,412 | -$718,470 | -$92,541 | $191,115 |
| % Margin | 22.3% | -68.7% | -10.3% | 17.6% |
| EPS Diluted | 4.08 | -11.74 | -1.52 | 3.11 |
| % Growth | 134.8% | -672.4% | -148.9% | – |
| Operating Cash Flow | $474,616 | $88,855 | $429,784 | $398,580 |
| Capital Expenditures | -$15,175 | $12,033 | -$38,881 | -$13,287 |
| Free Cash Flow | $459,441 | $100,888 | $390,903 | $385,293 |